Monday - April 20, 2026

Category Archives: Science

Von Willebrand Disease Market Outlook to 2034: Expanded FDA Approval of Takeda’s VONVENDI Strengthens Treatment Landscape | DelveInsight

Von Willebrand Disease Market Outlook DelveInsight’s latest report, “Von Willebrand Disease (VWD) – Market Insight, Epidemiology, and Market Forecast – 2034,” highlights how evolving therapies, regulatory milestones, and competition are shaping the VWD market across the 7MM (the US, EU4, … Continue reading →

Microsatellite Stable Colorectal Cancer Therapeutics Market Size in 7MM is expected to grow at a decent CAGR by 2032, DelveInsight

DelveInsight’s “Microsatellite Stable Colorectal Cancer Market Insights, Epidemiology, and Market Forecast- 2032” report delivers an in-depth understanding of the Microsatellite Stable Colorectal Cancer, historical and forecasted epidemiology as well as the Microsatellite Stable Colorectal Cancer market trends in the United … Continue reading →

PD-1+ NSCLC Pipeline Outlook 2025: Insights Into Therapies, Research, and Market Potential

DelveInsight’s, “PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) Pipeline Insight 2025” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) pipeline landscape. It covers the pipeline drug profiles, including clinical … Continue reading →

Metastatic Pancreatic Cancer Pipeline Outlook 2025: Insights Into Therapies, Research, and Market Potential

DelveInsight’s, “Metastatic Pancreatic Cancer Pipeline Insight 2025” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Metastatic Pancreatic Cancer pipeline landscape. It covers the Metastatic Pancreatic Cancer pipeline drugs profiles, including clinical and nonclinical stage products. It … Continue reading →

Pancreatic Ductal Adenocarcinoma Pipeline Outlook 2025: Insights Into Therapies, Research, and Market Potential

DelveInsight’s, “Pancreatic Ductal Adenocarcinoma Pipeline Insight 2025” report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Pancreatic Ductal Adenocarcinoma pipeline landscape. It covers the Pancreatic Ductal Adenocarcinoma pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Advanced Recurrent Ovarian Cancer Pipeline Outlook 2025: Insights Into Therapies, Research, and Market Potential

DelveInsight’s, “Advanced Recurrent Ovarian Cancer Pipeline Insight, 2025” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Advanced Recurrent Ovarian Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also … Continue reading →

HER2 Positive Gastric Cancer Pipeline Outlook 2025: Insights Into Therapies, Research, and Market Potential

DelveInsight’s, “HER2 Positive Gastric Cancer Pipeline Insight 2025” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in HER2 Positive Gastric Cancer pipeline landscape. It covers the HER2 Positive Gastric Cancer pipeline drug profiles, including clinical and nonclinical … Continue reading →